Nonetheless, our data open promising avenues for future research, including the role of IL-17A and associated immune pathways, as well as the potential impact of modulating specific microRNAs, such as miR-101 or miR-143, on migraine frequency and severity. Here, IL17A is linked to migraine disorder.